Apolipoprotein gene and its interaction with the environmentally driven risk factors

Molecular, genetic and epidemiological studies of Alzheimer's disease

Debomoy Lahiri, Kumar Sambamurti, David A. Bennett

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Herein we review the role of apolipoprotein E (ApoE) in Alzheimer's disease (AD) and how ApoE interacts with various risk factors. ApoE is localized with the major pathological hallmarks of AD, extracellular amyloid deposits and intracellular neurofibrillary tangles. The ApoEε4 allele is associated with the development of late-onset familial and sporadic AD. ApoEε4 has a gene dose effect on the risk and age of onset of AD. ApoE mRNA and protein are found predominantly in astrocytes within the CNS. There is also a high expression of ApoE mRNA in the brains of people with sporadic AD. ApoE acts as a cholesterol transporter in the brain. Cholesterol controls amyloid production and deposition by regulating β-secretase. In transgenic animal studies, ApoEε4 expression causes neuropathology and behavioral deficits. We also discuss data from three different cohorts for AD in the general population, in different racial and ethnic groups and the role of the ε4 allele in the clinical onset of the disease. Although the ε4 allele is an important genetic risk factor for AD, it accounts for a fairly small fraction of disease in the population. The effect of the ε4 allele on annual decline in episodic memory is significantly stronger than its effect on decline in other cognitive systems. Notably, the ε2 allele has an equal and opposite effect. Thus, ApoE allele status influences risk of AD by a relatively selective effect on episodic memory. Mechanistically, the role of APoE in AD needs to be established in terms of its gene expression, which ultimately controls levels of various ApoE isoforms. Transcriptional regulation suggests complex regulation of this gene and the resultant ApoE protein in injured neurons. We discuss the characteristics of ApoE regulatory elements, including their interactions with different transcription factors, to understand ApoE gene expression. Thus, ApoEε4 contributes to the pathogenesis of AD, but additional environmental risk factors will also be identified independent of ApoE and other genetic polymorphisms.

Original languageEnglish
Pages (from-to)651-660
Number of pages10
JournalNeurobiology of Aging
Volume25
Issue number5
DOIs
StatePublished - May 2004

Fingerprint

Apolipoproteins
Apolipoproteins E
Epidemiologic Studies
Molecular Biology
Alzheimer Disease
Genes
Apolipoprotein E4
Alleles
Episodic Memory
Cholesterol
Gene Expression
Amyloid Precursor Protein Secretases
Messenger RNA
Neurofibrillary Tangles
Genetically Modified Animals
Amyloid Plaques
Brain
Genetic Polymorphisms
Age of Onset
Ethnic Groups

Keywords

  • Aging
  • Amyloid
  • BACE
  • Beta-peptide
  • Brain
  • Cholesterol
  • Dementia
  • Epidemiology
  • Gene expression
  • Inflammation
  • Lipid rafts
  • Neurodegeneration
  • NF-κB
  • Promoter
  • Risk factor
  • Secretase
  • Transcription

ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry
  • Developmental Neuroscience
  • Neurology
  • Psychology(all)

Cite this

Apolipoprotein gene and its interaction with the environmentally driven risk factors : Molecular, genetic and epidemiological studies of Alzheimer's disease. / Lahiri, Debomoy; Sambamurti, Kumar; Bennett, David A.

In: Neurobiology of Aging, Vol. 25, No. 5, 05.2004, p. 651-660.

Research output: Contribution to journalArticle

@article{ed3dcac0fd04498eba08bd5f00165458,
title = "Apolipoprotein gene and its interaction with the environmentally driven risk factors: Molecular, genetic and epidemiological studies of Alzheimer's disease",
abstract = "Herein we review the role of apolipoprotein E (ApoE) in Alzheimer's disease (AD) and how ApoE interacts with various risk factors. ApoE is localized with the major pathological hallmarks of AD, extracellular amyloid deposits and intracellular neurofibrillary tangles. The ApoEε4 allele is associated with the development of late-onset familial and sporadic AD. ApoEε4 has a gene dose effect on the risk and age of onset of AD. ApoE mRNA and protein are found predominantly in astrocytes within the CNS. There is also a high expression of ApoE mRNA in the brains of people with sporadic AD. ApoE acts as a cholesterol transporter in the brain. Cholesterol controls amyloid production and deposition by regulating β-secretase. In transgenic animal studies, ApoEε4 expression causes neuropathology and behavioral deficits. We also discuss data from three different cohorts for AD in the general population, in different racial and ethnic groups and the role of the ε4 allele in the clinical onset of the disease. Although the ε4 allele is an important genetic risk factor for AD, it accounts for a fairly small fraction of disease in the population. The effect of the ε4 allele on annual decline in episodic memory is significantly stronger than its effect on decline in other cognitive systems. Notably, the ε2 allele has an equal and opposite effect. Thus, ApoE allele status influences risk of AD by a relatively selective effect on episodic memory. Mechanistically, the role of APoE in AD needs to be established in terms of its gene expression, which ultimately controls levels of various ApoE isoforms. Transcriptional regulation suggests complex regulation of this gene and the resultant ApoE protein in injured neurons. We discuss the characteristics of ApoE regulatory elements, including their interactions with different transcription factors, to understand ApoE gene expression. Thus, ApoEε4 contributes to the pathogenesis of AD, but additional environmental risk factors will also be identified independent of ApoE and other genetic polymorphisms.",
keywords = "Aging, Amyloid, BACE, Beta-peptide, Brain, Cholesterol, Dementia, Epidemiology, Gene expression, Inflammation, Lipid rafts, Neurodegeneration, NF-κB, Promoter, Risk factor, Secretase, Transcription",
author = "Debomoy Lahiri and Kumar Sambamurti and Bennett, {David A.}",
year = "2004",
month = "5",
doi = "10.1016/j.neurobiolaging.2003.12.024",
language = "English",
volume = "25",
pages = "651--660",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Apolipoprotein gene and its interaction with the environmentally driven risk factors

T2 - Molecular, genetic and epidemiological studies of Alzheimer's disease

AU - Lahiri, Debomoy

AU - Sambamurti, Kumar

AU - Bennett, David A.

PY - 2004/5

Y1 - 2004/5

N2 - Herein we review the role of apolipoprotein E (ApoE) in Alzheimer's disease (AD) and how ApoE interacts with various risk factors. ApoE is localized with the major pathological hallmarks of AD, extracellular amyloid deposits and intracellular neurofibrillary tangles. The ApoEε4 allele is associated with the development of late-onset familial and sporadic AD. ApoEε4 has a gene dose effect on the risk and age of onset of AD. ApoE mRNA and protein are found predominantly in astrocytes within the CNS. There is also a high expression of ApoE mRNA in the brains of people with sporadic AD. ApoE acts as a cholesterol transporter in the brain. Cholesterol controls amyloid production and deposition by regulating β-secretase. In transgenic animal studies, ApoEε4 expression causes neuropathology and behavioral deficits. We also discuss data from three different cohorts for AD in the general population, in different racial and ethnic groups and the role of the ε4 allele in the clinical onset of the disease. Although the ε4 allele is an important genetic risk factor for AD, it accounts for a fairly small fraction of disease in the population. The effect of the ε4 allele on annual decline in episodic memory is significantly stronger than its effect on decline in other cognitive systems. Notably, the ε2 allele has an equal and opposite effect. Thus, ApoE allele status influences risk of AD by a relatively selective effect on episodic memory. Mechanistically, the role of APoE in AD needs to be established in terms of its gene expression, which ultimately controls levels of various ApoE isoforms. Transcriptional regulation suggests complex regulation of this gene and the resultant ApoE protein in injured neurons. We discuss the characteristics of ApoE regulatory elements, including their interactions with different transcription factors, to understand ApoE gene expression. Thus, ApoEε4 contributes to the pathogenesis of AD, but additional environmental risk factors will also be identified independent of ApoE and other genetic polymorphisms.

AB - Herein we review the role of apolipoprotein E (ApoE) in Alzheimer's disease (AD) and how ApoE interacts with various risk factors. ApoE is localized with the major pathological hallmarks of AD, extracellular amyloid deposits and intracellular neurofibrillary tangles. The ApoEε4 allele is associated with the development of late-onset familial and sporadic AD. ApoEε4 has a gene dose effect on the risk and age of onset of AD. ApoE mRNA and protein are found predominantly in astrocytes within the CNS. There is also a high expression of ApoE mRNA in the brains of people with sporadic AD. ApoE acts as a cholesterol transporter in the brain. Cholesterol controls amyloid production and deposition by regulating β-secretase. In transgenic animal studies, ApoEε4 expression causes neuropathology and behavioral deficits. We also discuss data from three different cohorts for AD in the general population, in different racial and ethnic groups and the role of the ε4 allele in the clinical onset of the disease. Although the ε4 allele is an important genetic risk factor for AD, it accounts for a fairly small fraction of disease in the population. The effect of the ε4 allele on annual decline in episodic memory is significantly stronger than its effect on decline in other cognitive systems. Notably, the ε2 allele has an equal and opposite effect. Thus, ApoE allele status influences risk of AD by a relatively selective effect on episodic memory. Mechanistically, the role of APoE in AD needs to be established in terms of its gene expression, which ultimately controls levels of various ApoE isoforms. Transcriptional regulation suggests complex regulation of this gene and the resultant ApoE protein in injured neurons. We discuss the characteristics of ApoE regulatory elements, including their interactions with different transcription factors, to understand ApoE gene expression. Thus, ApoEε4 contributes to the pathogenesis of AD, but additional environmental risk factors will also be identified independent of ApoE and other genetic polymorphisms.

KW - Aging

KW - Amyloid

KW - BACE

KW - Beta-peptide

KW - Brain

KW - Cholesterol

KW - Dementia

KW - Epidemiology

KW - Gene expression

KW - Inflammation

KW - Lipid rafts

KW - Neurodegeneration

KW - NF-κB

KW - Promoter

KW - Risk factor

KW - Secretase

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=2542441462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542441462&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2003.12.024

DO - 10.1016/j.neurobiolaging.2003.12.024

M3 - Article

VL - 25

SP - 651

EP - 660

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 5

ER -